4//SEC Filing
Pfeffer Cary 4
Accession 0000899243-21-036399
CIK 0001640455other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 1:38 PM ET
Size
8.1 KB
Accession
0000899243-21-036399
Insider Transaction Report
Form 4
Pfeffer Cary
Director
Transactions
- Other
Common Stock
2021-09-15−0→ 0 total(indirect: See footnote)
Holdings
- 0(indirect: See footnote)
Common Stock
- 50,468
Common Stock
Footnotes (4)
- [F1]Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. ("TRV II"), TRV II distributed for no consideration, 1,750,000 shares of Common Stock of the Issuer (the "Shares") on September 15, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. ("TRV GP II"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended. After the reported transaction, TRV II directly holds 2,697,829 shares of Common Stock.
- [F2]The Reporting Person is a partner of TRV GP II, which is the general partner of TRV II. The Reporting Person disclaims beneficial ownership over the 2,697,829 shares held by TRV II, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F3]Third Rock Ventures III, L.P. ("TRV III") directly holds 3,048,780 shares of the Issuer's Common Stock. The Reporting Person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]The shares are directly held by the Reporting Person. Includes Shares received in the distributions described in footnote (1) above.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001591092
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 1:38 PM ET
- Size
- 8.1 KB